Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiological Assessment of Optic Nerve and Retinal Functions Following Intravitreal Injection of Bevacizumab (Avastin).

NCT01361828 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT01361828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01361828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiological Assessment of Optic Nerve and Retinal Functions Following Intravitreal Injection of Bevacizumab (Avastin).
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2010
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascular membrane